DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438–51.
Johnson RH, Anders CK, Litton JK, Ruddy KJ, Bleyer A. Breast cancer in adolescents and young adults. Pediatr Blood Cancer. 2018;65(12): e27397.
Kataoka A, Iwamoto T, Tokunaga E, Tomotaki A, Kumamaru H, Miyata H, et al. Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry. Breast Cancer Res Treat. 2016;160(1):163–72.
Article PubMed PubMed Central Google Scholar
Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg. 2009;208(3):341–7.
Article PubMed PubMed Central Google Scholar
Ruddy KJ, Gelber SI, Tamimi RM, Ginsburg ES, Schapira L, Come SE, et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32(11):1151–6.
Touraine P, Chabbert-Buffet N, Plu-Bureau G, Duranteau L, Sinclair AH, Tucker EJ. Premature ovarian insufficiency. Nat Rev Dis Primer. 2024;10(1):63.
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022–33.
Su HI, Lacchetti C, Letourneau J, Partridge AH, Qamar R, Quinn GP, et al. Fertility Preservation in People With Cancer: ASCO Guideline Update. J Clin Oncol. 2025;43(12):1488–515.
Steckler AM, Dizon DS, Higel-Mcgovern C, Duffy CM. A qualitative analysis on the awareness of surrogacy as an alternative parenting option for people diagnosed with cancer. J Clin Oncol. 2024;42(16_suppl):e24097–e24097.
Swain M, Miller M, Cannella C, Daviskiba S. Disparities in fertility preservation among patients diagnosed with female breast cancer. J Assist Reprod Genet. 2023;40(12):2843–9.
Article PubMed PubMed Central Google Scholar
Young K, Shliakhtsitsava K, Natarajan L, Myers E, Dietz AC, Gorman JR, et al. Fertility counseling before cancer treatment and subsequent reproductive concerns among female adolescent and young adult cancer survivors. Cancer. 2019;125(6):980–9.
Bentsen L, Pappot H, Hjerming M, Colmorn LB, Macklon KT, Hanghøj S. How do young women with cancer experience oncofertility counselling during cancer treatment? A qualitative, single centre study at a Danish tertiary hospital. Cancers. 2021;13(6):1355. https://doi.org/10.3390/cancers13061355.
Khan SZ, Arecco L, Villarreal-Garza C, Sirohi B, Ponde NF, Habeeb B, et al. Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast Cancer. JCO Glob Oncol. 2022;8: e2100153.
Article PubMed PubMed Central Google Scholar
Cakmak H, Katz A, Cedars MI, Rosen MP. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril. 2013;100(6):1673–80.
Tsampras N, Roberts SA, Gould D, Fitzgerald CT. Ovarian response to controlled ovarian stimulation for fertility preservation before oncology treatment: A retrospective cohort of 157 patients. Eur J Cancer Care (Engl). 2018;27(2): e12797.
von Wolff M, Capp E, Jauckus J, Strowitzki T, Germeyer A. Timing of ovarian stimulation in patients prior to gonadotoxic therapy: an analysis of 684 stimulations. Eur J Obstet Gynecol Reprod Biol. 2016;199:146–9.
Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(16):2630–5.
Kim J, Turan V, Oktay K. Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer. J Clin Endocrinol Metab. 2016;101(4):1364–71.
Article CAS PubMed PubMed Central Google Scholar
Meirow D, Raanani H, Maman E, Paluch-Shimon S, Shapira M, Cohen Y, et al. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. Fertil Steril. 2014;102(2):488-495.e3.
Article CAS PubMed Google Scholar
Arecco L, Blondeaux E, Bruzzone M, Ceppi M, Latocca MM, Marrocco C, et al. Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis. Hum Reprod Oxf Engl. 2022;37(5):954–68.
Lambertini M, Peccatori FA, Demeestere I, Amant F, Wyns C, Stukenborg JB, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines(†). Ann Oncol Off J Eur Soc Med Oncol. 2020;31(12):1664–78.
Lambertini M, Goldrat O, Toss A, Azim HAJ, Peccatori FA, Ignatiadis M, et al. Fertility and pregnancy issues in BRCA-mutated breast cancer patients. Cancer Treat Rev. 2017;59:61–70.
Lambertini M, Goldrat O, Ferreira AR, Dechene J, Azim HAJ, Desir J, et al. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients. Ann Oncol Off J Eur Soc Med Oncol. 2018;29(1):237–43.
Jensen AK, Macklon KT, Fedder J, Ernst E, Humaidan P, Andersen CY. 86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children. J Assist Reprod Genet. 2017;34(3):325–36.
Anderson RA, Amant F, Braat D, D’Angelo A, Chuva de Sousa Lopes SM, Demeestere I, et al. ESHRE guideline: female fertility preservation. Hum Reprod Open. 2020;2020(4):hoaa052.
Lambertini M, Horicks F, Del Mastro L, Partridge AH, Demeestere I. Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application. Cancer Treat Rev. 2019;72:65–77.
Article CAS PubMed Google Scholar
Cvetanovic AS, Lambertini M, Punie K, Matovina Brko GG, Zivkovic ND, Popovic MJ, et al. Pharmacological methods for ovarian function and fertility preservation in women with cancer: A literature review. Oncol Res. 2024;32(8):1309–22.
Article PubMed PubMed Central Google Scholar
Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, et al. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data. J Clin Oncol Off J Am Soc Clin Oncol. 2018;36(19):1981–90.
Lambertini M, Boni L, Michelotti A, Magnolfi E, Cogoni AA, Mosconi AM, et al. Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients. J Natl Cancer Inst. 2022;114(3):400–8.
Moore HCF, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, et al. Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy. N Engl J Med. 2015;372(10):923–32.
Article CAS PubMed PubMed Central Google Scholar
Lee IT, Humphries LA, Shah DK. Oocyte Donation, Gestational Carriers, and Adoption for Breast Cancer Survivors. Curr Breast Cancer Rep. 2020;12(4):361–6.
Muñoz E, Fernandez I, Martinez M, Tocino A, Portela S, Pellicer A, et al. Oocyte donation outcome after oncological treatment in cancer survivors. Fertil Steril. 2015;103(1):205–13.
Steckler AM, Raker C, Sauerbrun-Cutler MT, Graff SL, Dizon DS, Duffy C. Awareness of gestational surrogacy among female patients treated for cancer: A national survey [Internet]. Meeting Abstract presented at: 2025 ASCO Annual Meeting; 2025; Chicago, IL. Available from: https://meetings.asco.org/abstracts-presentations/245220. Accessed 20 May 2025
Steckler AM, Raker C, Sauerbrun-Cutler MT, Dizon DS, Graff SL, Duffy C. Inclusion of gestational surrogacy in oncologist-led fertility counseling at cancer diagnosis: A national survey [Internet]. Meeting Abstract presented at: 2025 ASCO Annual Meeting; 2025; Chicago, IL. Available from: https://meetings.asco.org/abstracts-presentations/245221. Accessed 20 May 2025
Ellington TD, Wardell AC, Deal AM, Mersereau J, Cameron K, Spandorfer S, et al. In vitro fertilization with cryopreserved oocytes or embryos after cancer: The role of gestational carriers. Cancer. 2025;131(8): e35844.
Perkins KM, Boulet SL, Jamieson DJ, Kissin DM. Trends and outcomes of gestational surrogacy in the United States. Fertil Steril. 2016;106(2):435-442.e2.
Article PubMed PubMed Central Google Scholar
Perkins KM, Boulet SL, Levine AD, Jamieson DJ, Kissin DM. Differences in the utilization of gestational surrogacy between states in the U.S. Reprod Biomed Soc Online. 2018;5:1–4.
Gorman JR, Whitcomb BW, Standridge D, Malcarne VL, Romero SAD, Roberts SA, et al. Adoption consideration and concerns among young adult female cancer survivors. J Cancer Surviv Res Pract. 2017;11(1):149–57.
Comments (0)